← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
Yu Jeffrey
Officer
Identity: SEC owner CIK matched through an unambiguous cached owner-name crosswalk · Reporting-owner CIK: 0001991132
Purchase history
- Companies traded
- 1
- Purchases · 12M
- 8
- Purchases · 24M
- 8
- Average purchase
- $284.5K
- Median purchase
- $100.0K
- Gross purchase value
- $2.3M
Companies: OneMedNet Corp
8 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-10-13 | OneMedNet Corp | ONMD | Officer | $250.0K | Open filing |
| 2026-09-14 | OneMedNet Corp | ONMD | Officer | $90.0K | Open filing |
| 2026-06-24 | OneMedNet Corp | ONMD | Officer | $100.0K | Open filing |
| 2026-06-17 | OneMedNet Corp | ONMD | Officer | $100.0K | Open filing |
| 2026-04-24 | OneMedNet Corp | ONMD | Officer | $750.0K | Open filing |
| 2025-11-26 | OneMedNet Corp | ONMD | Officer | $17.2K | Open filing |
| 2025-11-26 | OneMedNet Corp | ONMD | Officer | $959.6K | Open filing |
| 2025-11-26 | OneMedNet Corp | ONMD | Officer | $8.9K | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 7Developing | 100.0% (7/7) | 71.4% (5/7) | +13.8% | +12.7% | -10.5% |
| 20D | 7Developing | 100.0% (7/7) | 14.3% (1/7) | -12.4% | -13.8% | -43.9% |
| 60D | 6Developing | 100.0% (6/6) | 33.3% (2/6) | -53.0% | -34.0% | -56.6% |
| 120D | 3Small Sample | 75.0% (3/4) | 0.0% (0/3) | -50.1% | -50.1% | -50.1% |
Research patterns
- First purchase in 12M
- 1/8
- Large purchase ≥ $100k
- 4/8
- Cluster buying · 15D
- 7/8
- Buying the dip
- 8/8
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.